Tom Thomas
Background
I completed my undergraduate medical training at the University of East Anglia in 2016. Whilst at medical school, I was involved in clinical research in Gastroenterology. Alongside my clinical training at the Queen Elizabeth Hospital Birmingham (2016-2018), I was also a member of the Institute of Applied Health Research at the University of Birmingham. This offered me an insight into population-based epidemiology and disease association studies in gastroenterology as well as other immune mediated inflammatory disorders.
As part of my DPhil, I am investigating the cellular drivers of inflammation across Crohn’s disease, ulcerative colitis and rheumatoid arthritis with a focus on identifying mechanisms behind non-response to anti-tumour necrosis factor alpha therapy.
Research Interests
- Cellular drivers of inflammation across Crohn’s disease, ulcerative colitis and rheumatoid arthritis
- Mechanisms behind non-response to anti-tumour necrosis factor alpha therapy across the immune mediated inflammatory diseases
- Use of routine longitudinal laboratory biomarkers in aiding risk stratification across the immune mediated inflammatory diseases in collaboration with the Department of Engineering Sciences
Recent publications
Fibroblasts as immune regulators in infection, inflammation and cancer.
Journal article
Davidson S. et al, (2021), Nature reviews. Immunology, 21, 704 - 717
GLOBAL SMOKING TRENDS IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF INCEPTION COHORTS
Conference paper
Li VSW. et al, (2019), GUT, 68, A86 - A86